Durham.

PositionTriangle

DURHAM--Inspire Pharmaceuticals says it will continue to develop its drug Azasite as a treatment for blepharitis, an inflammation of the eyelids, though it failed to show significant improvements over existing treatments during clinical trials. The drug has been...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT